| 1 |
33887217 | Divergent Regulation of Alveolar Type 2 Cell and Fibroblast Apoptosis by Plasminogen Activator Inhibitor 1 in Lung Fibrosis. | 2021 Jul |
1 |
| 2 |
29777878 | Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis. | 2018 Aug |
1 |
| 3 |
28273432 | p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis. | 2017 May |
1 |
| 4 |
28722352 | Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease. | 2017 Oct |
1 |
| 5 |
25451236 | Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis. | 2015 Jan |
2 |
| 6 |
24024554 | Plasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury. | 2014 Feb |
1 |
| 7 |
23665346 | Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. | 2013 Jul |
1 |
| 8 |
21239537 | Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. | 2011 May |
2 |
| 9 |
21734232 | The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice. | 2011 Aug 25 |
2 |
| 10 |
20388759 | Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis. | 2010 Apr |
5 |
| 11 |
20501949 | The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. | 2010 Jun |
2 |
| 12 |
19697510 | Role of cytokines and proteases in murine scleroderma. | 2008 Sep |
1 |
| 13 |
17331968 | Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs. | 2007 Jun |
1 |
| 14 |
15730388 | Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma. | 2005 Mar |
5 |
| 15 |
14982862 | The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. | 2004 Mar |
4 |
| 16 |
12875966 | Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. | 2003 Aug |
2 |
| 17 |
12376355 | Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. | 2002 Nov |
1 |
| 18 |
11104787 | Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. | 2000 Dec |
2 |
| 19 |
10515451 | Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes. | 1999 Sep 20 |
1 |
| 20 |
8550840 | Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. | 1996 Jan 1 |
3 |
| 21 |
7544811 | Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. | 1995 Sep |
1 |